MediSys Research Admin

  1. Home
  2. Author: MediSys Research Admin
Author
MediSys Research Admin
Author
MediSys Research Admin Articles
Acute Generalized Exanthematous Pustulosis in an African American Male Caused by Trimethoprim-Sulfamethoxazole
Acute Generalized Exanthematous Pustulosis in an African American Male Caused by Trimethoprim-Sulfamethoxazole
August 10, 2020
0
Moshe Y. Bressler, Jeremy Minkowitz, Naeha Pathak, Andrew Mekaiel, Rebecca Tamez
Learn More
Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
August 4, 2020
1
Jiang C, Xie M, Cervellione K, Thurm C. Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study. BMC Res Notes. 2020;13(1):368. Published 2020 Aug 3. doi:10.1186/s13104-020-05210-2
Learn More
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
May 29, 2020
9
Kinevant Sciences GmbH, KIN-1901-2001
Learn More
A Contemporary Review of Radiation Pneumonitis
A Contemporary Review of Radiation Pneumonitis
May 29, 2020
8
Tofura Ullah , Harsh Patel , Grace M Pena , Rakesh Shah , Alan M Fein
Learn More
Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study
Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study
May 15, 2020
12
Richard J Durrance, Tofura Ullah, Harsh Patel, Grace Martinez, Kelly Cervellione, Veronica B Zafonte, Khalid Gafoor, Farshad Bagheri
Learn More
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
April 29, 2020
13
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
Learn More
Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange
Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange
April 5, 2020
16
Chuan Jiang,  Grace Nabila Martinez Pena,  Meng Xie2 and  Khalid Gafoor
Learn More
A FATAL CASE OF INTENTIONAL ETHYLENE GLYCOL POISONING WITH SIGNIFICANT BRAIN CHANGES ON MR IMAGING
A FATAL CASE OF INTENTIONAL ETHYLENE GLYCOL POISONING WITH SIGNIFICANT BRAIN CHANGES ON MR IMAGING
April 5, 2020
16
Jahir, Tahmina; Khan, Aizaaz; Gafoor, Khalid; Patel, Mahendra
Learn More
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
April 3, 2020
16
https://clinicaltrials.gov/ct2/show/NCT04292730?cond=remdesivir&draw=2&rank=6
Learn More
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
April 3, 2020
16
https://clinicaltrials.gov/ct2/show/NCT04292899?cond=remdesivir&draw=2&rank=5
Learn More
Recent Posts
Acute Generalized Exanthematous Pustulosis in an African American Male Caused by Trimethoprim-Sulfamethoxazole
August 10, 2020
Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.
August 4, 2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
May 29, 2020
A Contemporary Review of Radiation Pneumonitis
May 29, 2020
Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study
May 15, 2020
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
April 29, 2020
Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange
April 5, 2020
A FATAL CASE OF INTENTIONAL ETHYLENE GLYCOL POISONING WITH SIGNIFICANT BRAIN CHANGES ON MR IMAGING
April 5, 2020
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
April 3, 2020
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
April 3, 2020